In the BioHarmony Drug Report Database

"Preview" Icon

Lubiprostone

Amitiza (lubiprostone) is a small molecule pharmaceutical. Lubiprostone was first approved as Amitiza on 2006-01-31. It is used to treat constipation and irritable bowel syndrome in the USA. The pharmaceutical is active against chloride channel protein 2. Amitiza’s patents are valid until 2027-10-25 (FDA).

 

Trade Name

 

Amitiza
 

Common Name

 

lubiprostone
 

ChEMBL ID

 

CHEMBL1201134
 

Indication

 

constipation, irritable bowel syndrome
 

Drug Class

 

Prostaglandins

Image (chem structure or protein)

Lubiprostone structure rendering